TrialNature medicine2024

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.

Zefei Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.